Do the new findings about the resveratrol derivative SRT-1720 extending the normally shortened lifespan of obese mice tell us anything new? It’s been a long and ultimately disappointing road with the red wine derivative resveratrol, once touted as the basis for miracle anti-aging drugs and now a fading star. As I have described here before, resveratrol was purported to activate an enzyme system known as sirtuins, which in turn activate anti-aging genes that trigger a unique lifespan extension phenomenon normally associated with severe caloric restriction. Take a pill and skip the starvation diet was the promise, and live up to 40% longer. The idea was so compelling that the biotech company Sirtris was founded to exploit more potent (and patentable) resveratrol derivatives such as SRT-1720. This latest report showed that giving mice resveratrol after rendering them morbidly obese through an unhealthy diet helped them live longer than they normally would have, by improving insulin s...
Research in the area of wine and health has exploded in recent years and in this blog I sort through it to see what is really useful. For a definitive resource please refer to my book Age Gets Better with Wine: New Science for a Healthier, Better, and Longer Life.